摘要
目的探讨125I放射性粒子治疗无法切除的晚期肺癌的临床意义。方法自2005年1月～2007年10月,采用胸腔镜下肿瘤内粒子植入治疗晚期肺癌39例,观察患者术后生存率及症状缓解情况。结果术后肺不张缓解率95.2%(20/21),疼痛缓解率82.8%(24/29);术后6个月生存率97.4%(38/39),12个月生存率89.7%(35/39),18个月生存率56.4%(22/39),24个月以上生存率46.2%(18/39);其他症状也明显缓解。结论对于手术无法切除的晚期肺癌患者(主要为ⅢB患者),125I放射性粒子胸腔镜下植入近距离组织间照射治疗较传统放疗优势明显:微小的创伤,精确的定位,可靠的疗效,最小的副作用,是治疗晚期肺癌、延长患者生存时间、提高生存质量的新途径。
[Objective] To explore the significance of implanting 125I radioactive seeds to treat advanced lung cancer that can not be removed by operation. [Methods] From January 2005 to October 2007, 39 advanced lung cancer patients were treated with implanted seeds by video-assisted thoracoscopic surgery (VATS). [Results] The results showed that after the operation, the remission rate of pulmonary atelectasis was 95.2% (20/21) and the rate of pain was 82.8% (24/29). The 6-month, 12-month, 18-month and over-24-month ...
出处
《中国内镜杂志》
CSCD
北大核心
2008年第9期900-901,905,共3页
China Journal of Endoscopy
关键词
胸腔镜
125I
粒子
肺癌
video-assisted thoracoscopic surgery
125I
seeds
lung cancer
